USA flag logo/image

An Official Website of the United States Government

Hyperspectral Retinal Imaging for Assessment of Retinal Laser Damage

Award Information

Agency:
Department of Defense
Branch:
Air Force
Award ID:
92744
Program Year/Program:
2010 / SBIR
Agency Tracking Number:
F083-029-0024
Solicitation Year:
N/A
Solicitation Topic Code:
AF 08-029
Solicitation Number:
N/A
Small Business Information
Kestrel Corporation
3815 Osuna Road NE Albuquerque, NM 87109-4430
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 2
Fiscal Year: 2010
Title: Hyperspectral Retinal Imaging for Assessment of Retinal Laser Damage
Agency / Branch: DOD / USAF
Contract: FA8650-10-C-6124
Award Amount: $749,992.00
 

Abstract:

This Phase II program builds upon the success of the Phase I conceptual design effort, in which novel architectures and techniques were developed in order to create a wide-band hyperspectral fundus imager. This device allows hyperspectral retinal images to be collected over the entire transmission range of the eye, an unprecedented capability. The device is designed to allow an adaptive optics module to be included to further improve image quality. As a part of this effort, a unique light box has been designed. The research program refines the Phase I designs, including tolerancing and athermalization tasks, in order to create a robust hardware platform. Kestrel''s existing code base will be leveraged to provide a feature-rich software environment. At the end of the program, the wide-band hyperspectral retinal imager will be delivered to AFRL to support on-going research programs. In addition, this platform and identified derivatives, can be manufactured in Phase III and delivered to combat field hospitals. BENEFIT: The benefits of this research are (a) a family of hyperspectral fundus imagers able to operate over a greatly extended wavelength range, (b) a unique fundus camera able to operate over greatly extended wavelength range (c) the ability to identify (mild) laser eye damage by spectral signature, thus making better damage threshold information possible and enabling more quantitative research into appropriate treatments, and (d) the instruments will be used as standardized platforms for other ophthalmic instruments with similar requirements. Commercially, this research will result in four standard products to be commercialized.

Principal Investigator:

Boyd Hunter
CTO
5053452327
bhunter@kestrelcorp.com

Business Contact:

Eugene Butler
President
5053452327
gbutler@kestrelcorp.com
Small Business Information at Submission:

Kestrel Corporation
3815 Osuna Road NE Albuquerque, NM 87109

EIN/Tax ID: 850413423
DUNS: N/A
Number of Employees:
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No